188 related articles for article (PubMed ID: 2417429)
1. Hepatocellular carcinoma--an update.
Sinha SN
P N G Med J; 1985 Jun; 28(2):83-8. PubMed ID: 2417429
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma.
Haydon GH; Hayes PC
Br J Hosp Med; 1995 Feb 1-14; 53(3):74-80. PubMed ID: 7537155
[TBL] [Abstract][Full Text] [Related]
3. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.
Paul SB; Chalamalasetty SB; Vishnubhatla S; Madan K; Gamanagatti SR; Batra Y; Gupta SD; Panda SK; Acharya SK
Oncology; 2009; 77(3-4):162-71. PubMed ID: 19641335
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma].
Lemoine A; Azoulay D; Jezequel-Cuer M; Debuire B
Pathol Biol (Paris); 1999 Nov; 47(9):903-10. PubMed ID: 10609270
[TBL] [Abstract][Full Text] [Related]
6. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
7. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
8. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
[TBL] [Abstract][Full Text] [Related]
9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
10. [HBs antigen: marker of the relation between hepatitis B virus and primary cancer of the liver: the situation in Brazzaville in 1984].
Gombe CM
IARC Sci Publ; 1984; (63):221-6. PubMed ID: 6100270
[TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
12. [Primary hepatocellular carcinoma. Relation between serum and liver alpha fetoprotein, B virus infection, histology].
Maggi G; Bighellini K; Borghi L
Minerva Dietol Gastroenterol; 1985; 31(4):627-33. PubMed ID: 2418386
[No Abstract] [Full Text] [Related]
13. Primary hepatocellular carcinoma.
Hodgson HJ
Br J Hosp Med; 1983 Mar; 29(3):240, 246, 250 passim. PubMed ID: 6191818
[No Abstract] [Full Text] [Related]
14. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
15. Viral hepatitis and hepatocellular carcinoma.
Sallie R; Di Bisceglie AM
Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
[TBL] [Abstract][Full Text] [Related]
16. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
Stránský J; Zichová M; Vodák M
Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
18. [Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].
Pedreira JD; Vargas V; Vilaseca J; Esteban R; Hernández-Sánchez JM; Guardia J; Bacardi R
Med Clin (Barc); 1980 Jun; 75(2):58-60. PubMed ID: 6249978
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
20. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
